Porcilis Glässer is the first vaccine against Glässer's disease to pass the EU regulatory standards.
Porcilis Glässer
- The first vaccine against Glässer’s disease to pass the EU regulatory standards
- Porcilis Glässer has a rapid onset of immunity with a long duration - Proven protection from 2 weeks after 2nd dose, with immunity lasting for 14 to 17 weeks
- Porcilis Glässer, based on Haemophilus parasuis serotype 5 and Diluvac Forte, has been shown to provide (cross-) protection against pathogenic serotypes 1, 5, 12, 13, and 14
More information:
- Porcilis Glässer description
- Porcilis Glässer product brochure:
